Erin McEvoy

A new request for information, expert roundtable findings, and a transatlantic workshop signal FDA's renewed focus on plant-based drug products.

The comprehensive review synthesizes mechanistic and clinical evidence on the probiotic strain's role in enhancing non-heme iron absorption.

Congress has pushed back the 0.4 mg THC cap by one month, giving supplement brands additional time before the new hemp definition takes effect.

New preclinical research on Elissara by Monteloeder, SL, point to multiple mechanisms of action for the four-botanical ingredient, examining effects on DHT-related enzymes, cell proliferation, and oxidative stress.

The company will exhibit at Vitafoods Asia, Bharat Nutraverse Expo, SOHO Expo, as well as the Future Nutra Innovation Summit and The Outlook on Active Nutrition.

BBB National Programs’ National Advertising Division upheld Kendal Nutricare's core ingredient claim, but recommended changes to nutrition, breast milk, and brand heritage messaging.

This marks the third NSF/ANSI 173 certification for Cata-Kor's products, arriving alongside independent HPLC testing showing label inaccuracies among Amazon brands.

The facility expansion adds capacity for grape seed extract and crystal color production, aiming to meet rising demand for natural color solutions.

At Vitafoods Asia, the Vitux-developed technology aims to give formulators an alternative to conventional tablets and capsules across multiple categories.

The first-time exhibitor will showcase its joint health, healthy aging, sports nutrition, and beverage-friendly ingredient portfolio at Vitafoods Asia.

Ahead of the September Bangkok event, NXT USA outlines the science behind four ingredients targeting some of the supplement industry's most active categories.

Dr. Weber’s background spans naturopathic medicine, epidemiology, and clinical trials of herbal interventions.

With Gayton appointed SVP of merchandising, the retailer signals continuity in its approach to brand partnerships and private-label development.

A placebo-controlled study on Ixoreal's standardized root extract points to reductions in hot flashes, stress, and mood symptoms after eight weeks of supplementation.

A new double-blind trial reports metabolic and cognitive benefits in midlife women, building on the brand's expanding clinical trial program and recent $27M investment.

The physician-founded brand pairs its HPLC-verified polyphenol base with Greek beetroot for a new endurance-focused formula.

Alongside TocoGaia liver health data, the company will present healthy aging findings on STGaia and pet wellness results for PetGaia.

HPLC testing of products purchased on Amazon found 12 of 25 flagged brands contained nearly no detectable vitamin C.

In light of generic "gut health" claims in the market, brands that clearly support and label the specific mechanisms of their ingredients—fiber's physicochemical effects vs prebiotics' microbiome-selective action—stand to differentiate rather than commoditize.

The nonprofit's September 8 programming will address market entry, regulatory strategy, and East-West collaboration.

New research from ILSI U.S. and Canada and Balchem quantifies how phytates and oxalates limit calcium absorption across food supplies in different regions.

A new peer-reviewed study in Toxicology Reports calculated a margin of safety for TruCBN, adding to the safety data set behind the sleep-focused cannabinol ingredient.

New program offers product testing database and compliance tools to help retailers distinguish legal kratom products from synthetic compounds.

A look at the research, safety data, and quality-control challenges shaping the berberine ingredient market for supplement manufacturers.

The Centrum-focused ISMOS study aims to fill a data gap in an underrepresented population, following prior research on vitamins and metabolic syndrome risk.

With a federal THC cap deadline approaching, explore the regulatory history, industry self-regulation efforts, and cannabinoid innovation shaping the hemp supplement market.

Results from the 12-week clinical trial link a targeted probiotic formula to measurable improvements in menopausal symptoms and quality of life.

As a federal THC cap looms, industry leaders weigh in on what the new hemp definition means for brands and formulators.

PhytoGaia's palm fruit extract ingredient earns the award ahead of a clinical data presentation on skin and coat health at Vitafoods Asia 2026.

Clinical trial finds 200 mg of bio-optimized berberine improves blood glucose, GLP-1, and lipid markers at doses lower than conventional berberine.